Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Orphanet Journal of Rare Diseases|December 30, 2025
Assessing rare disease understanding: a novel disease readiness level frameworkKazuki Kitahara, Shingo KanoExpert Opinion on Therapeutic Patents|February 17, 2016
Strategic balance of drug lifecycle management options differs between domestic and foreign companies in JapanTakayuki Yamanaka, Shingo KanoTherapeutic Innovation & Regulatory Science|April 20, 2021
Integrated Analytical Framework for the Development of Artificial Intelligence-Based Medical DevicesHirokazu Arima, Shingo KanoTherapeutic Innovation & Regulatory Science|September 4, 2018
Technology Forecasting for Medical Devices Guidance Formulation: A Case Study in JapanSayaka Itoh, Shingo KanoHeliyon|January 7, 2026
Corrigendum to "Cost-effectiveness of multigene sequencing test and treatment for metastatic non-small cell lung cancer: A unique setting in the initial adoption phase in Japan allowing testing only after standard treatment" [Heliyon Volume 10, Issue 19, October 2024, Article e37867]Naoko Shiraiwa, Shingo KanoDrug Discovery Today|November 22, 2015
Mapping lifecycle management activities for blockbuster drugs in Japan based on drug approvals and patent term extensionsTakayuki Yamanaka, Shingo KanoDrug Discovery Today|September 12, 2015
Patent term extension systems differentiate Japanese and US drug lifecycle managementTakayuki Yamanaka, Shingo KanoTherapeutic Innovation & Regulatory Science|March 28, 2024
International Comparison of Qualification Process for Medical Product Development ToolsDaichi Uchijima, Shingo KanoRegenerative Medicine|June 21, 2023
Comparative analysis of rule elements for transportation of cell therapy products among regulations and standardsYoshihiko Okamura, Shingo KanoPageof 3